HCA Healthcare, Inc. $HCA Shares Bought by QRG Capital Management Inc.

Key Points

• QRG Capital Management Inc. increased its holdings in HCA Healthcare by 15.4% in the second quarter, now owning approximately 0.06% of the company, valued at about $57.73 million.
• HCA Healthcare reported an earnings per share (EPS) of $6.84 for the last quarter, surpassing analysts' expectations of $6.20, with a year-over-year revenue increase of 6.4%.
• The company recently declared a quarterly dividend of $0.72 per share, representing an annual yield of 0.7% and a payout ratio of 12.11%.

QRG Capital Management Inc. raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 15.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 150,703 shares of the company's stock after buying an additional 20,162 shares during the period. QRG Capital Management Inc. owned about 0.06% of HCA Healthcare worth $57,734,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Nuveen LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $569,217,000. Pacer Advisors Inc. lifted its holdings in shares of HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares during the last quarter. Finally, Abdiel Capital Advisors LP purchased a new stake in shares of HCA Healthcare during the first quarter valued at $164,835,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $429.52 on Friday. The firm has a market cap of $100.50 billion, a price-to-earnings ratio of 18.05, a P/E/G ratio of 1.34 and a beta of 1.40. The business's 50-day simple moving average is $397.53 and its 200-day simple moving average is $372.39. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $432.36.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

HCA has been the subject of several analyst reports. Wells Fargo & Company reduced their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Royal Bank Of Canada dropped their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. Barclays upped their price target on HCA Healthcare from $390.00 to $445.00 and gave the company an "overweight" rating in a research report on Thursday, September 18th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Truist Financial upped their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $407.75.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.